Laurence Collette

发表

P126 Including literature data in individual patient data meta-analyses for time-to-event endpoints

Luc Bijnens, Richard Sylvester, Laurence Collette, 1997 .

Sample size computation in phase II designs combining the A’Hern design and the Sargent and Goldberg design

Laurence Collette, Anouk Neven, Murielle Mauer, 2020, Journal of biopharmaceutical statistics.

Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.

Thomas Filleron, Murielle Mauer, Simone Mathoulin-Pélissier, 2013, European journal of cancer.

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.

Laurence Collette, L. Collette, J. Witjes, 2002, European urology.

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

Laurence Collette, Gilles Calais, L. Collette, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).

Karin Haustermans, Simone Mathoulin-Pélissier, Julien Taieb, 2014, European journal of cancer.

Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

Laurence Collette, Jean-Pascal Machiels, François Jamar, 2012, European urology.

Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.

Andrew Bottomley, Suresh Senan, Corinne Faivre-Finn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Michael Koller, Corneel Coens, Andrew Bottomley, 2020, The Lancet. Oncology.

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Thomas Gruenberger, Laurence Collette, Peter M Schlag, 2008, The Lancet.

Clinical trial designs for predictive marker validation in cancer treatment trials.

Daniel J Sargent, Laurence Collette, L. Collette, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: results of a DLT-TARGETT international survey.

Percy Ivy, Xavier Paoletti, Laurence Collette, 2014, European journal of cancer.

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.

Jacques Bernier, Michel Bolla, Laurence Collette, 1997, Radiotherapy and Oncology.

Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.

Michel Bolla, Akos Gulyban, Laurence Collette, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate cancer: pT3N0M0 prostate cancer: a plea for adjuvant radiation

Michel Bolla, Laurence Collette, L. Collette, 2009, Nature Reviews Urology.

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Laurence Collette, Rodrigo Arriagada, Erik Van Limbergen, 2015, The New England journal of medicine.

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

Michel Bolla, Laurence Collette, John Kurtz, 2008, European journal of cancer.

Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.

Vincenzo Valentini, Philippe Lambin, Laurence Collette, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning.

Damien C Weber, Akos Gulyban, Erik Roelofs, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-Term Follow-Up of an EORTC Randomized Prospective Trial Comparing Intravesical Bacille Calmette-Guerin-RIVM and Mitomycin C in Superficial Bladder Cancer

Richard Sylvester, Laurence Collette, J. A. Witjes, 1999 .

Chemotherapy with preoperative radiotherapy in rectal cancer.

Laurence Collette, Gilles Calais, L. Collette, 2006, The New England journal of medicine.

One‐step TNM staging of high‐risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all‐in‐one” imaging approach?

Laurence Collette, François Jamar, Nicolas Michoux, 2014, The Prostate.

Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals.

Tomasz Burzykowski, Laurence Collette, L. Collette, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data

Caroline Domerg, Stefan Michiels, Herbert Pang, 2013, The Lancet. Oncology.

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Laurence Collette, Jos J. Jager, Harry Bartelink, 2007 .

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

Jacques Bernier, Michel Bolla, Laurence Collette, 2002, The Lancet.